Product NDC: | 0069-0067 |
Proprietary Name: | OXALIPLATIN |
Non Proprietary Name: | OXALIPLATIN |
Active Ingredient(s): | 50 mg/10mL & nbsp; OXALIPLATIN |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0067 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200979 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120809 |
Package NDC: | 0069-0067-01 |
Package Description: | 10 mL in 1 VIAL (0069-0067-01) |
NDC Code | 0069-0067-01 |
Proprietary Name | OXALIPLATIN |
Package Description | 10 mL in 1 VIAL (0069-0067-01) |
Product NDC | 0069-0067 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | OXALIPLATIN |
Dosage Form Name | POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120809 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
Substance Name | OXALIPLATIN |
Strength Number | 50 |
Strength Unit | mg/10mL |
Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |